annual meeting program - American Society of Clinical Oncology

9:30 AM - 12:30 PM
ORAL ABSTRACT SESSION
Pediatric Oncology II
Location: S504
CME credit: 3
Track(s): Pediatric Oncology
Monday, June 7, 2010
Gregory T. Armstrong, MD, MSCE—Co-Chair
St. Jude Children’s Research Hospital
Tara O. Henderson, MD, MPH—Co-Chair
The University of Chicago
9:30 AM Anthracycline-related cardiomyopathy in childhood cancer survivors and
association with polymorphisms in the carbonyl reductase genes:
A Children’s Oncology Group study. (Abstract #9512)
J. G. Blanco, C. Sun, W. Landier, L. Chen, K. C. Oeffinger, M. M. Hudson,
J. P. Neglia, A. K. Ritchey, M. V. Relling, S. Bhatia
9:45 AM Late cardiac status in long-term survivors of childhood high-risk ALL 8 years
after continuous or bolus infusion of doxorubicin: The DFCI Childhood ALL
91–01 randomized trial. (Abstract #9513)
S. E. Lipshultz, S. R. Lipsitz, T. L. Miller, D. S. Neuberg, S. E. Dahlberg,
S. D. Colan, L. B. Silverman, L. L. Cushman, J. M. Henkel, S. E. Sallan, The
Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium
10:00 AM Chronic medical conditions, health status, and health care practices at 25
years in 5-year survivors of Wilms tumor: A report from the Childhood
Cancer Survivor study. (Abstract #9514)
A. M. Termuhlen, J. M. Tersak, Y. Yasui, Q. Liu, M. Stovall, M. Deutsch,
C. A. Sklar, K. C. Oeffinger, L. L. Robison, D. M. Green
Discussion
10:15 AM Melissa M. Hudson, MD (Abstracts #9512–9514)
St. Jude Children’s Research Hospital
Cardiac Status in Survivors of Pediatric Cancer
10:30 AM Childhood cancer: Do females experience more acute toxicities than males?
A Report from the Children’s Oncology Group (Abstract #9515)
K. A. Meeske, L. Ji, A. Butturini, D. R. Freyer, P. S. Gaynon, K. Ruccione,
R. Sposto, N. L. Seibel, S. E. Siegel
10:45 AM MIBG scoring as a prognostic indicator in patients with stage IV
neuroblastoma: A COG study. (Abstract #9516)
G. A. Yanik, M. T. Parisi, A. Naranjo, K. K. Matthay, W. B. London, P. W. McGrady,
S. G. Kreissman, B. L. Shulkin
11:00 AM Racial and ethnic disparities in disease presentation and survival among
children with neuroblastoma (NBL): A Children’s Oncology Group (COG)
study. (Abstract #9517)
S. L. Cohn, S. Bhatia, W. B. London, P. W. Mcgrady, C. Crotty, C. Sun,
T. O. Henderson
11:15 AM Clinical and biological features predictive of survival after relapse of
neuroblastoma: A study from the International Neuroblastoma (NB) Risk
Group (INRG) Database. (Abstract #9518)
W. B. London, K. K. Matthay, P. F. Ambros, T. Monclair, A. D. Pearson, S. L. Cohn,
V. Castel
Discussion
11:30 AM Andrew Pearson, MD, FRCP (Abstracts #9515–9518)
The Institute of Cancer Research
Prognostic Variables in Neuroblastoma
347
MONDAY